The 1 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +10.19% increase from the last price of 3.63.
The current consensus among 1 polled investment analysts is to Buy stock in Atossa Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.28
Reporting Date Aug 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.